DRUG · Unmapped registry intervention
DIO-902
Find medicine records ·
Find other trials using this name
Clinical trial
Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
NCT00622089
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
DIO-902
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
DIO-902
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedOpen Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2, PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
DiObexlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00622089 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.